These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 3053749

  • 1. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
    Capaldo B, Napoli R, Di Marino L, Picardi A, Riccardi G, Sacca L.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
    [Abstract] [Full Text] [Related]

  • 2. Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes.
    Capaldo B, Santoro D, Riccardi G, Perrotti N, Saccà L.
    J Clin Invest; 1986 Apr; 77(4):1285-90. PubMed ID: 2870077
    [Abstract] [Full Text] [Related]

  • 3. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [Abstract] [Full Text] [Related]

  • 4. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation.
    Yki-Järvinen H, Puhakainen I, Koivisto VA.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1268-77. PubMed ID: 2026747
    [Abstract] [Full Text] [Related]

  • 5. Role of insulin and free fatty acid (FFA) availability on regional FFA kinetics in the human forearm.
    Capaldo B, Napoli R, Di Marino L, Guida R, Pardo F, Saccá L.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):879-82. PubMed ID: 8077375
    [Abstract] [Full Text] [Related]

  • 6. Glucose and gluconeogenic substrate exchange by the forearm skeletal muscle in hyperglycemic and insulin-treated type II diabetic patients.
    Capaldo B, Napoli R, Di Bonito P, Albano G, Saccà L.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1220-3. PubMed ID: 2229281
    [Abstract] [Full Text] [Related]

  • 7. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
    Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA.
    J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
    [Abstract] [Full Text] [Related]

  • 8. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
    Zancanaro C, Cigolini M, Bonora E, Moghetti P, Cacciatori V, Querena M, Muggeo M.
    Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
    [Abstract] [Full Text] [Related]

  • 9. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
    Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism.
    Avogaro A, Valerio A, Miola M, Crepaldi C, Pavan P, Tiengo A, del Prato S.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2285-90. PubMed ID: 8964865
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U, Müller R, Berger W.
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [Abstract] [Full Text] [Related]

  • 20. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H, Taskinen MR, Kiviluoto T, Hilden H, Helve E, Koivisto VA, Nikkilä EA.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.